Jpmorgan Chase & Co »

Inhibrx shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 52k 38.00
2023-09-30 $6.8M 370k 18.35
2023-06-30 $9.5M 367k 25.96
2023-03-31 $754k 40k 18.86
2022-12-31 $795k 32k 24.64
2022-06-30 $289k 25k 11.40
2022-03-31 $527k 24k 22.31
2021-12-31 $2.7M 61k 43.65
2021-03-31 $0 19k 0.00
2020-12-31 $744k 23k 33.07